BCAB vs TT · $5.9M cap vs P/E 36, rev $21.32B
Bioatla Inc (BCAB) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
BCAB currently screens at market cap $5.9M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the BCAB and TT stock pages for the full models.
Not investment advice.